Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Press Releases

Qr8 Health™ announces the launch of PST Snapshot™ and Cognition Snapshot™

qr8 health

Qr8 Health, Inc a digital health company developing standardized, patient self-administered digital tests for the measurement of neurological and motor function announced today that is has launched two commercial FDA registered products, PST Snapshot™, a rapid digital cognitive function test that measures information processing speed and Cognition Snapshot™, a digital application that combines the PST (Processing Speed Test) with a test for visual memory (VMT). Processing speed and memory are often negatively affected in neurological disorders such as Alzheimer’s disease and Parkinson’s disease and are important to identify as they have the potential to be modified with cognitive training and future therapeutic interventions.

“We are pleased to make PST Snapshot and Cognition Snapshot commercially available as they enable a rapid and validated measurement of information processing speed and memory for use in clinical practice which traditionally has not had the time or resources to routinely measure cognitive function,” said Vincent Owens, Qr8 Health President and CEO, “We believe the ability to have regular, standardized cognitive assessments in everyday clinical practice will arm health care professionals with important information that will lead to interventions and improved patient outcomes”.

PST Snapshot is a validated digital application based on the symbol-digit modalities test (SDMT), a symbol substitution neuropsychological test that examines a person’s attention and speed of processing. Cognition Snapshot is a digital application that combines PST Snapshot with a visual memory test based upon the 7/24 Spatial Recall Test and has been designed and validated to measure episodic memory and delayed learning. These apps may be used where either processing speed, memory or both are affected by neurological conditions.

Unlike traditional neuropsychological tests which require a technician to administer and score them, PST Snapshot and Cognition Snapshot are patient self-administered. The results from both PST Snapshot and Cognition Snapshot are automatically scored and norm-adjusted, taking into account demographic variables including age and level of education.

PST Snapshot and Cognition Snapshot are the first of several neurological and motor assessments that Qr8 Health have in development.

About Qr8 Health
Qr8 Health, Inc is a digital health company developing standardized, validated, patient self-administered digital tests for the measurement of neurological and motor function along with patient reported outcomes that can be administered on a mobile tablet device and easily integrated into electronic health records. Founded in 2016, the company has been working to develop applications that quantitatively measure neurological and motor function which are often affected in many brain disorders but are not routinely assessed in clinical practice. For more information visit http://www.qr8health.com.

Contact Investors and Media:
David Blum
info@qr8health.com

Source